查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595136

氧化再生纤维素止血材料市场：按最终用户、分销管道划分 - 全球预测 2025-2030 年

Oxidized Regenerated Cellulose Based Hemostats Market by End User (Clinic, Infectious Diseases), Distribution Channel (Direct Sales, Retail Sales) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年氧化再生纤维素基止血材料市场价值为18,263万美元，预计2024年将达20,507万美元，复合年增长率为12.38%，2030年将达4亿美元，预计将达到13.45美元百万。

氧化再生纤维素（ORC）基止血材料是重要的生物可吸收材料，主要用于控製手术过程中的出血。这些止血材料因其快速止血和生物相容性而成为首选，这使得它们对于需要快速凝血的外科应用至关重要。这包括心血管外科、整形外科和普通外科的应用。最终用途多种多样，包括医院、专科诊所和门诊手术中心。基于ORC的止血材料的市场成长主要是由于外科手术数量的增加、对先进外科产品的认识不断提高以及最大限度地减少外科併发症的需要推动的。此外，止血材料的技术进步和微创手术的普及也是关键的成长要素。然而，严格的监管要求、高成本以及某些患者可能出现发炎反应等因素可能会限制市场扩张。然而，改善生物相容性的研究正在进行中，而复合止血材料（将 ORC 与其他材料结合）的开发存在着有利可图的机会。鼓励公司专注于与医疗保健提供者的策略伙伴关係关係，以扩大其产品范围，并投资于研发，以在创伤治疗和军事医疗干预等更广泛的应用领域进行创新。探索生物分解性的ORC 配方来提高术中控制和精确度也可以提供显着的竞争优势。对于进入或拓展该市场的公司来说，重点应该是透过合规性克服监管障碍，并透过展示改善的患者治疗效果来赢得市场信任。此外，识别快速成长的医疗保健市场（尤其是新兴国家）中未满足的需求可以提供重大的成长机会。儘管市场竞争仍然激烈，但未来性充满希望，持续的技术创新和对多功能止血解决方案的日益重视预计将推动未来的成长。

主要市场统计
基准年[2023] 1.8263亿美元
预测年份 [2024] 20507万美元
预测年份 [2030] 41345万美元
复合年增长率（%） 12.38%

市场动态：快速发展的氧化再生纤维素止血剂市场的关键市场洞察

氧化再生纤维素止血剂市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 需要预先护理来处理手术伤口
    • 人口老化快速增加
    • 需要确保病人安全和早日康復
    • 纤维素基止血材料的经济性
  • 市场限制因素
    • 从业者对新产品的抗拒心理
    • 存在有吸引力的替代方案
  • 市场机会
    • 持续研发改良止血材料
    • 新兴国家的需求不断成长
  • 市场挑战
    • 患者敏感性问题

波特的五力策略工具驾驭氧化再生纤维素止血剂市场

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解氧化再生纤维素止血材料市场的外部影响

外部宏观环境因素在塑造氧化再生纤维素止血材料市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解氧化再生纤维素止血剂市场的竞争格局

对氧化再生纤维素基止血材料市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位基质氧化再生纤维素止血剂市场供应商绩效评估

FPNV定位矩阵是评估氧化再生纤维素基止血材料市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了氧化再生纤维素止血材料市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对氧化再生纤维素基止血材料市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 需要初步护理来处理手术伤口
      • 人口老化快速增加
      • 需要确保病人安全和早日康復
      • 纤维素止血材料价格实惠
    • 抑制因素
      • 从业者对新产品持消极态度
      • 有吸引力的替代品的可用性
    • 机会
      • 持续研发改良止血剂
      • 新兴国家的需求不断增加
    • 任务
      • 患者敏感性问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章氧化再生纤维素基止血材料市场：依最终用户分类

  • 诊所
  • 感染疾病

第七章氧化再生纤维素基止血材料市场：依通路分类

  • 直销
  • 零售

第八章美洲氧化再生纤维素止血剂市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区氧化再生纤维素止血剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲氧化再生纤维素止血剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
  • 战略分析和建议

公司名单

  • Aegis Lifesciences
  • Altaylar Medical
  • B. Braun SE
  • Betatech Medical
  • CuraMedical BV
  • GELITA MEDICAL GmbH
  • Hangzhou Singclean Medical Products Co., Ltd.
  • Healthium Medtech Limited
  • Johnson & Johnson Services, Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Synthesia, as
Product Code: MRR-4312A385A2FA

The Oxidized Regenerated Cellulose Based Hemostats Market was valued at USD 182.63 million in 2023, expected to reach USD 205.07 million in 2024, and is projected to grow at a CAGR of 12.38%, to USD 413.45 million by 2030.

Oxidized Regenerated Cellulose (ORC) based hemostats are crucial bioresorbable materials primarily used to control bleeding during surgical procedures. These hemostats are favored for their quick hemostatic action and biocompatibility, making them essential for applications in surgeries where rapid blood coagulation is required. This includes applications in cardiovascular, orthopedic, and general surgeries. The end-use scope spans across hospitals, specialty clinics, and ambulatory surgical centers. The market growth for ORC-based hemostats is primarily driven by the increasing number of surgical procedures, rising awareness about advanced surgical products, and the need for minimizing operative complications. Additionally, technological advancements in hemostatic materials and the growing adoption of minimally invasive surgeries are key growth factors. However, the market's expansion could be limited by factors such as strict regulatory requirements, high costs, and the potential for inflammatory responses in certain patients. Nevertheless, ongoing research into enhancing biocompatibility and the development of composite hemostatic agents (combining ORC with other materials) present lucrative opportunities. Companies are recommended to focus on strategic partnerships with healthcare providers to expand product reach and invest in R&D to innovate with broader applications, such as in trauma care and military medical interventions. Exploring biodegradable ORC formulations that offer more control and precision during surgery could also present a significant competitive edge. For a business entering or expanding in this market, the focus should be on overcoming regulatory hurdles through compliance and gaining market trust by demonstrating improved patient outcomes. Furthermore, identifying unmet needs in rapidly growing healthcare markets, particularly in emerging economies, could offer substantial growth opportunities. The nature of the market remains competitive yet promising, with ongoing innovation and an increasing emphasis on multi-functional hemostatic solutions poised to drive future growth.

KEY MARKET STATISTICS
Base Year [2023] USD 182.63 million
Estimated Year [2024] USD 205.07 million
Forecast Year [2030] USD 413.45 million
CAGR (%) 12.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oxidized Regenerated Cellulose Based Hemostats Market

The Oxidized Regenerated Cellulose Based Hemostats Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need for advance care to manage surgical wounds
    • Rapid growth in the aging population
    • Need to ensure patient safety and render rapid recovery
    • High affordability of cellulose-based hemostats
  • Market Restraints
    • Reluctance of practitioners towards new products
    • Availability of attractive substitutes
  • Market Opportunities
    • Ongoing research and development of improved hemostats
    • Increasing demand in emerging economies
  • Market Challenges
    • Patient sensitivity issues

Porter's Five Forces: A Strategic Tool for Navigating the Oxidized Regenerated Cellulose Based Hemostats Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oxidized Regenerated Cellulose Based Hemostats Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oxidized Regenerated Cellulose Based Hemostats Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oxidized Regenerated Cellulose Based Hemostats Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oxidized Regenerated Cellulose Based Hemostats Market

A detailed market share analysis in the Oxidized Regenerated Cellulose Based Hemostats Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oxidized Regenerated Cellulose Based Hemostats Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oxidized Regenerated Cellulose Based Hemostats Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oxidized Regenerated Cellulose Based Hemostats Market

A strategic analysis of the Oxidized Regenerated Cellulose Based Hemostats Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oxidized Regenerated Cellulose Based Hemostats Market, highlighting leading vendors and their innovative profiles. These include Aegis Lifesciences, Altaylar Medical, B. Braun SE, Betatech Medical, CuraMedical B.V., GELITA MEDICAL GmbH, Hangzhou Singclean Medical Products Co., Ltd., Healthium Medtech Limited, Johnson & Johnson Services, Inc., Meril Life Sciences Pvt. Ltd., and Synthesia, a.s..

Market Segmentation & Coverage

This research report categorizes the Oxidized Regenerated Cellulose Based Hemostats Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on End User, market is studied across Clinic and Infectious Diseases.
  • Based on Distribution Channel, market is studied across Direct Sales and Retail Sales.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for advance care to manage surgical wounds
      • 5.1.1.2. Rapid growth in the aging population
      • 5.1.1.3. Need to ensure patient safety and render rapid recovery
      • 5.1.1.4. High affordability of cellulose-based hemostats
    • 5.1.2. Restraints
      • 5.1.2.1. Reluctance of practitioners towards new products
      • 5.1.2.2. Availability of attractive substitutes
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development of improved hemostats
      • 5.1.3.2. Increasing demand in emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Patient sensitivity issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Oxidized Regenerated Cellulose Based Hemostats Market, by End User

  • 6.1. Introduction
  • 6.2. Clinic
  • 6.3. Infectious Diseases

7. Oxidized Regenerated Cellulose Based Hemostats Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Direct Sales
  • 7.3. Retail Sales

8. Americas Oxidized Regenerated Cellulose Based Hemostats Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Oxidized Regenerated Cellulose Based Hemostats Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Oxidized Regenerated Cellulose Based Hemostats Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aegis Lifesciences
  • 2. Altaylar Medical
  • 3. B. Braun SE
  • 4. Betatech Medical
  • 5. CuraMedical B.V.
  • 6. GELITA MEDICAL GmbH
  • 7. Hangzhou Singclean Medical Products Co., Ltd.
  • 8. Healthium Medtech Limited
  • 9. Johnson & Johnson Services, Inc.
  • 10. Meril Life Sciences Pvt. Ltd.
  • 11. Synthesia, a.s.

LIST OF FIGURES

  • FIGURE 1. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET RESEARCH PROCESS
  • FIGURE 2. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET DYNAMICS
  • TABLE 7. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY RETAIL SALES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023